Selpercatinib (LOXO-292) in patients with RET-Fusion+ non small-cell lung cancer (NSCLC)-MedSci.cn - 梅斯（MedSci）

Selpercatinib (LOXO-292) in patients with RET-Fusion+ non small-cell lung cancer (NSCLC)

Goto, K; Oxnard, G; Tan, DSWSW; Loong, HHF; Bauer, TT; Gainor, J; McCoach, C; Gautschi, O; Besse, B; Cho, BC; Peled, N; Weiss, J; Kim, Y; Ohe, Y; Horiike, A; Park, K; Huang, X; Olek, E; Subbiah, V; Drilon, A; Wolf, J

PNEUMOLOGIE, 2021; 75 (): S42

科室
- - 订阅+
  - 更多科室
工具
服务